DMD Simcyp

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yu, L. J.
Right arrow Articles by Waxman, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yu, L. J.
Right arrow Articles by Waxman, D. J.

Vol. 29, Issue 3, 304-312, March 2001

P450 Enzyme Expression Patterns in the NCI Human Tumor Cell Line Panel

Li J. Yu,1 Jocelyn Matias, Dominic A. Scudiero, Karen M. Hite, Anne Monks, Edward A. Sausville, and David J. Waxman

Division of Cell and Molecular Biology, Department of Biology, Boston University, Boston, Massachusetts (L.J.Y., J.M., D.J.W.); SAIC-Frederick, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, Maryland (D.A.S., K.M.H., A.M.); and Developmental Therapeutics Program, National Cancer Institute, Bethesda, Maryland (E.A.S.)

Cytochrome P450 (P450) enzyme expression patterns were determined for a panel of 60 human tumor cell lines, representing nine tumor tissue types, used by the National Cancer Institute (NCI) Anticancer Drug Screening Program. All 60 tumor cell lines displayed significant P450 activity, as well as P450 reductase activity, as determined using the general P450 substrate 7-benzyloxyresorufin. Cell line-specific P450 enzyme patterns were observed using three other P450 substrates, 7-ethoxycoumarin, coumarin, and 7-ethoxyresorufin, each of which was metabolized at a low rate. Using a pattern-matching computer program, COMPARE, correlative relationships were investigated between the arrays of P450 activities and the patterns of cytotoxicity exhibited by a large group of anticancer agents of proven or potential clinical utility. Significant negative correlations between the patterns of P450-dependent 7-benzyloxyresorufin metabolism activity and cell line chemosensitivity were observed for 10 standard anticancer agents (including 6 alkylating agents) and 55 investigational compounds, suggesting a role for P450 metabolism in the inactivation of these agents. Negative correlations between 7-ethoxycoumarin O-deethylation and cell line chemosensitivity to a group of topoisomerase inhibitors were also seen, again suggesting P450-dependent drug inactivation. P450 enzyme profiling may thus aid in interpreting the patterns of drug sensitivity and resistance in the NCI tumor cell panel, and may facilitate the identification of anticancer agents whose activity can be altered via cytochrome P450 metabolism.

1 Current address: Central Research Division, Pfizer Inc., Groton, CT.

Copyright © 2001 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 Proc. Natl. Acad. Sci. USAHome page
M.-Y. Lee, R. A. Kumar, S. M. Sukumaran, M. G. Hogg, D. S. Clark, and J. S. Dordick
Three-dimensional cellular microarray for high-throughput toxicology assays
PNAS, January 8, 2008; 105(1): 59 - 63.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
S.-L. Wang, J.-F. Han, X.-Y. He, X.-R. Wang, and J.-Y. Hong
Genetic Variation of Human Cytochrome P450 Reductase as a Potential Biomarker for Mitomycin C-Induced Cytotoxicity
Drug Metab. Dispos., January 1, 2007; 35(1): 176 - 179.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
M. Michael and M.M. Doherty
Tumoral Drug Metabolism: Overview and Its Implications for Cancer Therapy
J. Clin. Oncol., January 1, 2005; 23(1): 205 - 229.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
A. I. Loaiza-Perez, S. Kenney, J. Boswell, M. Hollingshead, M. C. Alley, C. Hose, H. P. Ciolino, G. C. Yeh, J. B. Trepel, D. T. Vistica, et al.
Aryl hydrocarbon receptor activation of an antitumor aminoflavone: Basis of selective toxicity for MCF-7 breast tumor cells
Mol. Cancer Ther., June 1, 2004; 3(6): 715 - 725.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
M. Rooseboom, J. N. M. Commandeur, and N. P. E. Vermeulen
Enzyme-Catalyzed Activation of Anticancer Prodrugs
Pharmacol. Rev., March 1, 2004; 56(1): 53 - 102.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. Ramji, C. Lee, T. Inaba, A. V. Patterson, and D. S. Riddick
Human NADPH-Cytochrome P450 Reductase Overexpression Does Not Enhance the Aerobic Cytotoxicity of Doxorubicin in Human Breast Cancer Cell Lines
Cancer Res., October 15, 2003; 63(20): 6914 - 6919.
[Abstract] [Full Text] [PDF]

Home page
 J Biomol ScreenHome page
K. A. Giuliano
High-Content Profiling of Drug-Drug Interactions: Cellular Targets Involved in the Modulation of Microtubule Drug Action by the Antifungal Ketoconazole
J Biomol Screen, April 1, 2003; 8(2): 125 - 135.
[Abstract] [PDF]

Home page
 Mol. Pharmacol.Home page
M. J. Kuffel, J. C. Schroeder, L. J. Pobst, S. Naylor, J. M. Reid, S. H. Kaufmann, and M. M. Ames
Activation of the Antitumor Agent Aminoflavone (NSC 686288) Is Mediated by Induction of Tumor Cell Cytochrome P450 1A1/1A2
Mol. Pharmacol., July 1, 2002; 62(1): 143 - 153.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
P. S. Schwartz and D. J. Waxman
Cyclophosphamide Induces Caspase 9-Dependent Apoptosis in 9L Tumor Cells
Mol. Pharmacol., December 1, 2001; 60(6): 1268 - 1279.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
L. Long and M. E. Dolan
Role of Cytochrome P450 Isoenzymes in Metabolism of O6-Benzylguanine: Implications for Dacarbazine Activation
Clin. Cancer Res., December 1, 2001; 7(12): 4239 - 4244.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2001 by the American Society for Pharmacology and Experimental Therapeutics.